Fraternity 'Rocks the Campus' in Memory of Brother Who Battled Lymphoma

Fraternity 'Rocks the Campus' in Memory of Brother Who Battled Lymphoma

RICHARDSON, Texas, Aug. 24 /PRNewswire/ -- The Texas Chi chapter of Sigma Alpha Epsilon fraternity will be hosting "Rock the Campus for the Cure" outside the Student Union of the University of Texas at Dallas on September 10, 2005. Gates open at 6:30 p.m. The concert will be honoring Sigma Alpha Epsilon fraternity brother Brad Monks, a student of UT Dallas who lost the battle with lymphoma this summer. The evening lineup includes Frolic, Fallen from the Nest, Generic, Rose Down and Sidekick Mafia -- all local bands that have donated their time and talents for the charitable cause. All proceeds will be donated to the North Texas Chapter of The Leukemia & Lymphoma Society. Tickets for the event are $10 each and can be purchased by making an online donation at http://www.texaschi.com/ . A live Web cast will be presented by Radio UTD the night of the event. For more information, please contact James Balandran at 817-874-4302 or jbalandran@texaschi.com .

Sigma Alpha Epsilon (SAE) is North America's largest social fraternity founded in 1856. Since then SAE has initiated over 275,000 members. The Texas Chi chapter is located at the University of Texas at Dallas in Richardson, Texas. For more information visit the chapter's Web site at http://www.texaschi.com/ .

The University of Texas at Dallas (UTD), located in Richardson, Texas, enrolls more than 13,000 students. The University offers a broad assortment of bachelor's, master's and doctoral degree programs. For additional information about UTD, please visit the University's Web site at http://www.utdallas.edu/ .

The Leukemia & Lymphoma Society is the world's largest voluntary health organization dedicated to funding blood cancer research, education and patient services. The Society's mission is to cure leukemia, lymphoma, Hodgkin's disease and myeloma, and to improve the quality of life of patients and their families. Since its founding in 1949, the Society has invested $424 million for research specifically targeting blood cancers to over 425 researchers in 120 institutions worldwide. Society-funded research has led to key advances in understanding blood cancers and has produced new treatments to enhance and prolong lives. Innovations in cancer treatment over the years have included radiation and chemotherapy, stem cell transplantation and new targeted therapies that kill cancer cells without harming normal cells. For more information, visit http://www.lls.org/ntx .

Source: The Leukemia & Lymphoma Society

CONTACT: James Balandran of Texas Chi chapter of Sigma Alpha Epsilon,
+1-817-874-4302, or jbalandran@texaschi.com

Web site: http://www.lls.org/ntx
http://www.texaschi.com/
http://www.utdallas.edu/

-------
Profile: intent